Tandem Diabetes Care, Inc. (LON:0M0F)
London flag London · Delayed Price · Currency is GBP · Price in USD
16.00
-0.05 (-0.31%)
At close: Jul 11, 2025

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $234.42M USD in the quarter ending March 31, 2025, with 22.30% growth. This brings the company's revenue in the last twelve months to $982.95M, up 27.65% year-over-year. In the year 2024, Tandem Diabetes Care had annual revenue of $940.20M with 25.74% growth.

Revenue (ttm)
$982.95M
Revenue Growth
+27.65%
P/S Ratio
1.01
Revenue / Employee
$370.92K
Employees
2,650
Market Cap
769.27M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 940.20M 192.49M 25.74%
Dec 31, 2023 747.72M -53.50M -6.68%
Dec 31, 2022 801.22M 98.42M 14.00%
Dec 31, 2021 702.80M 203.97M 40.89%
Dec 31, 2020 498.83M 136.53M 37.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
HSBC Holdings 44.89B
Shell 217.54B
Unilever 50.25B
British American Tobacco p.l.c. 25.87B
Rolls-Royce Holdings 18.91B
Rio Tinto Group 42.86B
RELX PLC 9.43B
Revenue Rankings